Order Article Reprints

Lombardi G, Barresi V, Indraccolo S, Simbolo M, Fassan M, Mandruzzato S, Simonelli M, Caccese M, Pizzi M, Fassina A, et al. Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study. Cancers. 2020; 12(8):2283. https://doi.org/10.3390/cancers12082283

Lombardi, Giuseppe, Valeria Barresi, Stefano Indraccolo, Michele Simbolo, Matteo Fassan, Susanna Mandruzzato, Matteo Simonelli, Mario Caccese, Marco Pizzi, Arianna Fassina, and et al. 2020. "Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study" Cancers 12, no. 8: 2283. https://doi.org/10.3390/cancers12082283

Lombardi, G., Barresi, V., Indraccolo, S., Simbolo, M., Fassan, M., Mandruzzato, S., Simonelli, M., Caccese, M., Pizzi, M., Fassina, A., Padovan, M., Masetto, E., Gardiman, M. P., Bonavina, M. G., Caffo, M., Persico, P., Chioffi, F., Denaro, L., Dei Tos, A. P., ... Zagonel, V. (2020). Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study. Cancers, 12(8), 2283. https://doi.org/10.3390/cancers12082283